News
IntroductionThe global vaccines market has witnessed unprecedented growth in recent years, driven by technological ...
Moderna’s combined Covid and flu shot outperformed the existing standalone vaccines for both viruses, according to the ...
Moderna is deprioritizing its flu/COVID combination vaccine in younger adults amid a push to cut about $1.5 billion from its ...
A new combination vaccine could simplify protection against two major respiratory illnesses for older adults, according to a ...
A Washington DC man was left excessively bleeding due to a rare side effect linked to his Covid vaccine booster.
More than 3,000 GPTs are reportedly in use at Moderna, which has partnered with OpenAI. Here's how they're using the technology.
A combination covid-19/flu vaccine could make it easier for people to get protection from both diseases. © Stockpot Videos via Shutterstock Moderna’s mRNA-based ...
The Food and Drug Administration has asked Moderna for additional data before it will consider approving a combination shot ...
A new vaccine that combines flu and COVID-19 protection in one shot shows promising results, but the U.S. Food and Drug ...
Moderna has tested its first flu and COVID combination vaccine shot. Dr. Bill Hartman from UW Health joined FOX6 to talk ...
Moderna's mRNA technology gained rapid validation as sales of its covid vaccine soared in 2021 and 2022, but we think the firm has yet to secure a narrow economic moat around its business ...
Moderna (NASDAQ:MRNA) accelerates cost cuts, trimming 2026 GAAP operating expenses by up to $500 million as COVID-19 vaccine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results